Robert E. Plaat

Robert E. Plaat

Auto-generated profile, based on publicly available information

Robert E. Plaat

Department of Otorhinolaryngology – Head and Neck Surgery, Medical Center Leeuwarden, Leeuwarden, The Netherlands

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2024 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
ATAlexandra Gillisa Lara Toppenberg
Alexandra Gillisa Lara Toppenberg
WLWouter L. Lodder
Wouter L. Lodder
RPRobert E. Plaat
Robert E. Plaat
LSLeonora Schwandt
Leonora Schwandt

11 April 2024 in Cancers
Verified
Journal Article
Open access
PDF file
ATAlexandra Gillisa Lara Toppenberg
Alexandra Gillisa Lara Toppenberg
TNThomas Sebastiaan Nijboer
Thomas Sebastiaan Nijboer
WLWisse G. W. J. van der Laan
Wisse G. W. J. van der Laan
JWJan Wedman
Jan Wedman
LSLeonora Schwandt
Leonora Schwandt
Gyorgy B HalmosGyorgy B Halmos
Gyorgy B Halmos
Transoral Robotic Surgery (TORS) is utilized for treating various malignancies, such as early-stage oropharyngeal cancer and lymph node metastasis of an unknown primary tumor (CUP), and also benign conditions, like obstructive sleep apnea (OSA) and chronic lingual tonsillitis. However, the success and failure of TORS have not been analyzed to date. In this retrospective observational multicenter cohort study, we evaluated patients treated with TORS using the da Vinci surgical system. Success criteria were defined as identification of the primary tumor for CUP, >2 mm resection margin for malignant conditions, and improvement on respiratory polygraphy and tonsillitis complaints for benign conditions. A total of 220 interventions in 211 patients were included. We identified predictors of success, such as low comorbidity status ACE-27, positive P16 status, and lower age for CUP, and female gender and OSA severity for benign conditions. For other malignancies, no predictors for success were found. Predictors of failure based on postoperative complications included high comorbidity scores (ASA) and anticoagulant use, and for postoperative pain, younger age and female gender were identified. This study provides valuable insights into the outcomes and predictors of success and failure in TORS procedures across various conditions and may also help in patient selection and counseling.